These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 9816026

  • 1. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
    Takahashi N, Sausville EA, Breitman TR.
    Clin Cancer Res; 1995 Jun; 1(6):637-42. PubMed ID: 9816026
    [Abstract] [Full Text] [Related]

  • 2. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
    Taimi M, Breitman TR.
    Biochem Biophys Res Commun; 1997 Mar 17; 232(2):432-6. PubMed ID: 9125196
    [Abstract] [Full Text] [Related]

  • 3. Induction of differentiation and covalent binding to proteins by the synthetic retinoids Ch55 and Am80.
    Takahashi N, Breitman TR.
    Arch Biochem Biophys; 1994 Oct 17; 314(1):82-9. PubMed ID: 7944409
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
    Ponzoni M, Bocca P, Chiesa V, Decensi A, Pistoia V, Raffaghello L, Rozzo C, Montaldo PG.
    Cancer Res; 1995 Feb 15; 55(4):853-61. PubMed ID: 7850799
    [Abstract] [Full Text] [Related]

  • 5. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
    Delia D, Aiello A, Lombardi L, Pelicci PG, Grignani F, Grignani F, Formelli F, Menard S, Costa A, Veronesi U.
    Cancer Res; 1993 Dec 15; 53(24):6036-41. PubMed ID: 8261419
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl) retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells.
    Dipietrantonio A, Hsieh TC, Wu JM.
    Biochem Biophys Res Commun; 1996 Jul 25; 224(3):837-42. PubMed ID: 8713132
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tunicamycin in combination with retinoic acid synergistically inhibits cell growth while decreasing palmitoylation and enhancing retinoylation of proteins in the human breast cancer cell line MCF-7.
    Takahashi N, Iwahori A, Breitman TR, Fukui T.
    Oncol Res; 1997 Jul 25; 9(10):527-33. PubMed ID: 9507530
    [Abstract] [Full Text] [Related]

  • 10. Cholecalciferol (vitamin D3) and the retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) are synergistic for chemoprevention of prostate cancer.
    Tokar EJ, Ancrile BB, Ablin RJ, Webber MM.
    J Exp Ther Oncol; 2006 Jul 25; 5(4):323-33. PubMed ID: 17024972
    [Abstract] [Full Text] [Related]

  • 11. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
    Xu H, Cheepala S, McCauley E, Coombes K, Xiao L, Fischer SM, Clifford JL.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):969-79. PubMed ID: 16467112
    [Abstract] [Full Text] [Related]

  • 12. Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl) retinamide.
    Pellegrini R, Mariotti A, Tagliabue E, Bressan R, Bunone G, Coradini D, Della Valle G, Formelli F, Cleris L, Radice P.
    Cell Growth Differ; 1995 Jul 01; 6(7):863-9. PubMed ID: 7547508
    [Abstract] [Full Text] [Related]

  • 13. Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line.
    Appierto V, Cavadini E, Pergolizzi R, Cleris L, Lotan R, Canevari S, Formelli F.
    Br J Cancer; 2001 Jun 01; 84(11):1528-34. PubMed ID: 11384104
    [Abstract] [Full Text] [Related]

  • 14. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
    Kazmi SM, Plante RK, Visconti V, Lau CY.
    Cancer Res; 1996 Mar 01; 56(5):1056-62. PubMed ID: 8640761
    [Abstract] [Full Text] [Related]

  • 15. In vitro effects of fenretinide on cell-matrix interactions.
    Vaccari M, Silingardi P, Argnani A, Horn W, Giungi M, Mascolo MG, Grilli S, Colacci A.
    Anticancer Res; 2000 Mar 01; 20(5A):3059-66. PubMed ID: 11062723
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of aromatase activity and expression in MCF-7 cells by the chemopreventive retinoid N-(4-hydroxy-phenyl)-retinamide.
    Ciolino HP, Wang TT, Sathyamoorthy N.
    Br J Cancer; 2000 Aug 01; 83(3):333-7. PubMed ID: 10917548
    [Abstract] [Full Text] [Related]

  • 17. Carcinoma cell lines resistant for growth inhibition and apoptosis to retinoic acid are responsive to 4-hydroxy-phenyl-retinamide: correlation with tissue transglutaminase.
    Chiantore MV, Giandomenico V, De Luca LM.
    Biochem Biophys Res Commun; 1999 Jan 27; 254(3):636-41. PubMed ID: 9920792
    [Abstract] [Full Text] [Related]

  • 18. The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase- dependent and independent of the retinoic acid receptor.
    Anding AL, Chapman JS, Barnett DW, Curley RW, Clagett-Dame M.
    Cancer Res; 2007 Jul 01; 67(13):6270-7. PubMed ID: 17616685
    [Abstract] [Full Text] [Related]

  • 19. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG, Appierto V, Cavadini E, Bettiga A, Prinetti A, Clagett-Dame M, Curley RW, Formelli F.
    Cancer Res; 2006 Mar 15; 66(6):3238-47. PubMed ID: 16540676
    [Abstract] [Full Text] [Related]

  • 20. Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide.
    Morales MC, Pérez-Yarza G, Nieto-Rementeria N, Boyano MD, Jangi M, Atencia R, Asumendi A.
    Anticancer Res; 2005 Mar 15; 25(3B):1945-51. PubMed ID: 16158929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.